Back
Hepion Pharmaceuticals Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
23
HEPA
Hepion Pharmaceuticals
Last Price:
0.63
Seasonality Move:
10.8%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HEPA is experiencing slight buying pressure.
Hepion Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.64 | Sell |
| 20-day SMA: | 0.67 | Sell |
| 50-day SMA: | 0.68 | Sell |
| 200-day SMA: | 1.29 | Sell |
| 8-day EMA: | 0.64 | Sell |
| 20-day EMA: | 0.66 | Sell |
| 50-day EMA: | 0.69 | Sell |
| 200-day EMA: | 1.73 | Sell |
Hepion Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 46.75 | Sell |
| Chaikin Money Flow: | 6250 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.6 - 0.72) | Sell |
| Bollinger Bands (100): | (0.62 - 0.92) | Sell |
Hepion Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Hepion Pharmaceuticals Stock
Is Hepion Pharmaceuticals Stock a Buy?
- Hepion Pharmaceuticals share price is 0.64 while HEPA 8-day simple moving average is 0.64, which is a Sell signal.
- The stock price of HEPA is 0.64 while Hepion Pharmaceuticals 20-day SMA is 0.67, which makes it a Sell.
- Hepion Pharmaceuticals 50-day simple moving average is 0.68 while HEPA share price is 0.64, making it a Sell technically.
- HEPA stock price is 0.64 and Hepion Pharmaceuticals 200-day simple moving average is 1.29, creating a Sell signal.
HEPA Technical Analysis vs Fundamental Analysis
Sell
23
Hepion Pharmaceuticals (HEPA)
is a Sell
Is Hepion Pharmaceuticals a Buy or a Sell?
-
Hepion Pharmaceuticals stock is rated a Sell
The current Hepion Pharmaceuticals [HEPA] share price is $0.64. The Score for HEPA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Hepion Pharmaceuticals Stock Info
Market Cap:
3.71M
Price in USD:
0.64
Share Volume:
18.88K
Hepion Pharmaceuticals 52-Week Range
52-Week High:
4.47
52-Week Low:
0.55
Sell
23
Hepion Pharmaceuticals (HEPA)
is a Sell
Hepion Pharmaceuticals Share Price Forecast
-
What is the Hepion Pharmaceuticals stock price today?
The Hepion Pharmaceuticals stock price is 0.64 USD today. -
Will HEPA stock go up or go down?
Hepion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Hepion Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Hepion Pharmaceuticals is overvalued.
Is Hepion Pharmaceuticals Stock a Buy?
- Hepion Pharmaceuticals share price is 0.64 while HEPA 8-day exponential moving average is 0.64, which is a Sell signal.
- The stock price of HEPA is 0.64 while Hepion Pharmaceuticals 20-day EMA is 0.66, which makes it a Sell.
- Hepion Pharmaceuticals 50-day exponential moving average is 0.69 while HEPA share price is 0.64, making it a Sell technically.
- HEPA stock price is 0.64 and Hepion Pharmaceuticals 200-day simple moving average is 1.73, creating a Sell signal.
Fundamental Analysis of Hepion Pharmaceuticals
Is Hepion Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.45 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Hepion Pharmaceuticals
Should I short Hepion Pharmaceuticals stock?
- HEPA Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Hepion Pharmaceuticals is a Sell
- Hepion Pharmaceuticals Relative Strength Index (RSI) is 46.75, which suggest Hepion Pharmaceuticals is oversold
- The Bollinger Bands (25) for Hepion Pharmaceuticals is (0.6 - 0.72), which suggest Hepion Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Hepion Pharmaceuticals is (0.62 - 0.92), which suggest Hepion Pharmaceuticals is a Sell
* Hepion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.